First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.44 USD -6.27% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
ADC Therapeutics SA?
Write Note

ADC Therapeutics SA
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Net Income (Common) Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Net Income (Common)
-$240.1m
CAGR 3-Years
1%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Net Income (Common)
-CHf54.6m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Net Income (Common)
-$217.1m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Net Income (Common)
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Net Income (Common)
-CHf297.9m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Net Income (Common)
-CHf13.7m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Net Income (Common)?
Net Income (Common)
-240.1m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Net Income (Common) amounts to -240.1m USD.

What is ADC Therapeutics SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-14%

Over the last year, the Net Income (Common) growth was -54%. The average annual Net Income (Common) growth rates for ADC Therapeutics SA have been 1% over the past three years , -14% over the past five years .